Galmed Pharmaceuticals Stock Forecast - Simple Regression
| GLMD Stock | USD 0.85 0.04 5.31% |
The Simple Regression forecasted value of Galmed Pharmaceuticals on the next trading day is expected to be 0.72 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.92. Galmed Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Galmed Pharmaceuticals stock prices and determine the direction of Galmed Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Galmed Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Galmed Pharmaceuticals' share price is below 20 . This usually indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.51) | EPS Estimate Current Year (2.31) | EPS Estimate Next Year (0.85) | Wall Street Target Price 12 | EPS Estimate Current Quarter (0.54) |
Using Galmed Pharmaceuticals hype-based prediction, you can estimate the value of Galmed Pharmaceuticals from the perspective of Galmed Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Galmed Pharmaceuticals on the next trading day is expected to be 0.72 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.92. Galmed Pharmaceuticals after-hype prediction price | USD 0.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Galmed Pharmaceuticals to cross-verify your projections. Galmed Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Galmed price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Galmed using various technical indicators. When you analyze Galmed charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Galmed Pharmaceuticals Simple Regression Price Forecast For the 24th of January
Given 90 days horizon, the Simple Regression forecasted value of Galmed Pharmaceuticals on the next trading day is expected to be 0.72 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.92.Please note that although there have been many attempts to predict Galmed Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Galmed Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Galmed Pharmaceuticals Stock Forecast Pattern
| Backtest Galmed Pharmaceuticals | Galmed Pharmaceuticals Price Prediction | Buy or Sell Advice |
Galmed Pharmaceuticals Forecasted Value
In the context of forecasting Galmed Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Galmed Pharmaceuticals' downside and upside margins for the forecasting period are 0.01 and 6.07, respectively. We have considered Galmed Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Galmed Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Galmed Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.6298 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0807 |
| MAPE | Mean absolute percentage error | 0.0825 |
| SAE | Sum of the absolute errors | 4.9197 |
Predictive Modules for Galmed Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Galmed Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Galmed Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Galmed Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Galmed Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Galmed Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Galmed Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Galmed Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Galmed Pharmaceuticals' historical news coverage. Galmed Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.05 and 6.27, respectively. We have considered Galmed Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Galmed Pharmaceuticals is risky at this time. Analysis and calculation of next after-hype price of Galmed Pharmaceuticals is based on 3 months time horizon.
Galmed Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Galmed Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Galmed Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Galmed Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.64 | 5.35 | 0.07 | 0.11 | 7 Events / Month | 5 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.85 | 0.92 | 7.85 |
|
Galmed Pharmaceuticals Hype Timeline
Galmed Pharmaceuticals is currently traded for 0.85. The entity has historical hype elasticity of 0.07, and average elasticity to hype of competition of -0.11. Galmed is expected to increase in value after the next headline, with the price projected to jump to 0.92 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 7.85%, whereas the daily expected return is currently at -0.64%. The volatility of related hype on Galmed Pharmaceuticals is about 3203.59%, with the expected price after the next announcement by competition of 0.74. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Historical Fundamental Analysis of Galmed Pharmaceuticals to cross-verify your projections.Galmed Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Galmed Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Galmed Pharmaceuticals' future price movements. Getting to know how Galmed Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Galmed Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIVI | Biovie Inc | 0.01 | 8 per month | 0.00 | (0.16) | 6.62 | (7.30) | 19.38 | |
| TOVX | Theriva Biologics | 0.01 | 10 per month | 0.00 | (0.11) | 10.53 | (11.11) | 35.76 | |
| MLEC | Moolec Science SA | (0.51) | 9 per month | 10.63 | 0.03 | 15.63 | (16.33) | 152.55 | |
| CMMB | Chemomab Therapeutics Ltd | (0.03) | 9 per month | 0.00 | (0.22) | 8.48 | (7.69) | 21.68 | |
| INM | InMed Pharmaceuticals | 0.02 | 8 per month | 0.00 | (0.15) | 7.48 | (9.30) | 30.84 | |
| BDRX | Biodexa Pharmaceticals | 1.55 | 9 per month | 0.00 | (0.05) | 11.45 | (16.09) | 128.35 | |
| VRAX | Virax Biolabs Group | 0.03 | 7 per month | 0.00 | (0.08) | 8.20 | (10.20) | 92.80 | |
| ELAB | Elevai Labs Common | (2.64) | 5 per month | 0.00 | (0.46) | 4.32 | (14.29) | 38.62 | |
| ISPC | iSpecimen | (0.11) | 9 per month | 0.00 | (0.1) | 11.54 | (12.50) | 37.80 | |
| NKGN | NKGen Biotech Common | 0.00 | 0 per month | 0.00 | 0.21 | 37.84 | (6.00) | 126.82 |
Other Forecasting Options for Galmed Pharmaceuticals
For every potential investor in Galmed, whether a beginner or expert, Galmed Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Galmed Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Galmed. Basic forecasting techniques help filter out the noise by identifying Galmed Pharmaceuticals' price trends.Galmed Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Galmed Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Galmed Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Galmed Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Galmed Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Galmed Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Galmed Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Galmed Pharmaceuticals stock market strength indicators, traders can identify Galmed Pharmaceuticals entry and exit signals to maximize returns.
Galmed Pharmaceuticals Risk Indicators
The analysis of Galmed Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Galmed Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting galmed stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.87 | |||
| Standard Deviation | 5.19 | |||
| Variance | 26.89 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Galmed Pharmaceuticals
The number of cover stories for Galmed Pharmaceuticals depends on current market conditions and Galmed Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Galmed Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Galmed Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Galmed Pharmaceuticals Short Properties
Galmed Pharmaceuticals' future price predictability will typically decrease when Galmed Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Galmed Pharmaceuticals often depends not only on the future outlook of the potential Galmed Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Galmed Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 930.8 K | |
| Cash And Short Term Investments | 15.3 M |
Check out Historical Fundamental Analysis of Galmed Pharmaceuticals to cross-verify your projections. For information on how to trade Galmed Stock refer to our How to Trade Galmed Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galmed Pharmaceuticals. If investors know Galmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galmed Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galmed Pharmaceuticals is measured differently than its book value, which is the value of Galmed that is recorded on the company's balance sheet. Investors also form their own opinion of Galmed Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Galmed Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galmed Pharmaceuticals' market value can be influenced by many factors that don't directly affect Galmed Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galmed Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Galmed Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galmed Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.